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Summary: Monoethanolamine, a frequent impurity of diethanolamine, inhibits the activity of the isoenzymes of
alkaline phosphatase to various extents. Isoenzymes from liver and bone, in particular, are strongly inhibited. Inhibition
is stronger at lower (25 °C) than at higher temperatures (37 °C).
Zum Einfluß von Monoethanolamin auf die Aktivitätsbestimmung der Isoenzyme der alkalischen Phosphatase
Zusammenfassung: Monoethanolamin als häufige Verunreinigung von Diethanolamin hemmt die Aktivität der Iso-
enzyme der alkalischen Phosphatase in unterschiedlichem Ausmaß. Besonders stark gehemmt werden die Isoenzyme
von Leber und Knochen. Die Hemmung ist bei niedrigen Meßtemperaturen (25 °C) stärker als bei höheren (37 °C).
In various countries (e. g. Federal Republic of Germany,
Scandinavian countries) the activity measurement of
alkaline phosphatase (orthophosphoric morioester
phosphohydrolase, EC 3.1.3.1) with diethanolamine
buffer is recommended as a standardised method (1, 2).
This enzyme activity was hitherto measured chiefly in
glycine buffer, but the activities measured in diethanol-
amine buffer are much higher, because the transphos-
phoryläse reaction is measured in addition to the
hydrolytic phosphatase (3, 4, 5). The reliability of this
method of measuring the activity of alkaline phosphatase
is, however, impaired by monoethanolamine, which may
occur as an impurity in diethanolamine and acts as an
inhibitor of alkaline phosphatase (6, 7). The aim of this
study is to show the different influence of mono-
ethanolamine on the activity of the various isoenzymes
of alkaline phosphatase.
Methods and Materials
Kinetic measurements of enzyme reaction velocity were per^
formed on an Eppendorf photometer (with recorder) at 405 nm
and 30 °C. Final concentrations in the mixture were 1 mol/1
diethanolamine (pH 9.8), 0.5 mmoi/1 MgCl2,10 mmol/14-
nitrophenylphosphate and the monoethanolamine concentrations
given below. Ratio of sample volume to final volume was 1 : 66.
The reaction was started by addition of 4-nitrophenylphosphate.
The rate of increase in absorbänce was monitored continuously.
The enzyme activities were calculated from the reaction rates
in the first two minutes and are mean values of double or triple
measurements. The precision within series (SD) for a serum of
168.4 U/l was characterised by SD of 1.77 U/l (n = 10). Iso-
enzymes of alkaline phosphatase prepared from 'bones, liver and
small intestine according to Gerhardt et al. (8) were used for
the investigation. The placental isoenzyme was obtained by
homogenisation of placenta in 150 mmol/1 Tris/HCl buffer
(pH 7.5) and 1 mmol/1 MgCl2 and by centrifugation for 15 min
at 20.000 g at 4°C. The isoenzymes were added to inactivated
serum (30 min, 65°C; no residual phosphatase activity).
Commercial diethanolamine was distilled on a column under
vacuum. The main fraction contained 99.8% diethanolamine,
0.2% triethanolamine; the monoethanolamine content was
below 0.01% (gas Chromatographie analysis as trifluoroacetyl
compound; Varian gas Chromatograph). 4-nitrophenylphosphate
and triethanolamine hydrochloride were products of Boehrin-
ger, Mannheim; MgCl2, and monoethanolamine (94.7% mono-
ethanolamine, 5.3% diethanolamine) were obtained from Labor-
chemie Apolda.
Results and Discussion
In checking the diethanolamine from various producers,
Bowers (6) found activities of alkaline phosphatase
between 82 and 100% and interpreted this as the
influence of monoethanolamine. We measured the
activities of the various isoenzymes of alkaline phos-
phatase in dependence on monoethanolamine concen-
tration in the test mixture. Monoethanolamine impurity
was simulated by adding monoethanolamine to mono-
ethanolaminefree diethanolamine. Concentrations of 1
to 60 mmol/1 monoethanolamine corresponding to a
content of 0.1 to 6% monoethanolamine in diethanol-
amine were tested at a final concentration of 1 mol/1 in
the test mixture (fig. 1). A monoethanolamine concen-
tration of < 5 mmol/1 in the test mixture inhibits the
isoenzymes of alkaline phosphatase, the various iso-
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Fig. 1. Influence of monoethanolamine concentration on
catalytic activity of the isoenzymes of alkaline phos-
phatase.
Conditions are given in the text; each point is the mean
of duplicate or triplicate. Isoenzymes prepared according
to Gerhardt et al. (8) were added to inactivated serum.
Catalytic activity in diethanolamine buffer with mono-
ethanolamine impurity is expressed as fraction of
that obtained in diethanolamine buffer without mono-
ethanolamine: small intestine 272.2 U/l X X; bone
310.1 U/l · ·; liver 118.2 U/l o ; placenta
297.7 U/l * A.
enzymes being influenced to different extents. In
particular the isoenzymes from liver and bone are
inhibited, while the activities of isoenzymes from small
intestine and placenta are less impaired. This different
influence of monoethanolamine is noteworthy,
because monoethanolamine may not only result in a
falsely low value, it may lead to the recording of a false
relationship between isoenzyme activities.
The extent of monoethanolamine inhibition of the iso-
enzymes of alkaline phosphatase is, to a considerable
extent, determined by the assay temperature. In
comparative investigations of monoethanolamine
Tab. 1. Influence of assay temperature on the monoethanol-
amine inhibition of the isoenzymes of alkaline phosphatase.
Measurements were made as described in the text;
60 mmol/l monoethanolamine as final concentration in
the test mixture. Catalytic activity is expressed as
fraction (mean ± S.D., = 3) of that obtained in
diethanolamine buffer without monoethanolamine; at
25°C and 379C (in brackets), respectively: small intestine
252.3 U/l (337.7 U/l); bone 248.7 U/l (375.7 U/l);
liver 96.7 U/l (151 U/l); placenta 210 U/l (364.8 U/l).
Statistical evaluation was .performed by means of t-test.
25°C
fraction
37°C significance
small intestine
bone
liver
placenta
0.811 ± 0.004
0.5 84 ±0.004
0.619 ± 0.003
0.790 ± 0.008
0,875 ± 0.006
0.650 ± 0.007
0.672 ±0.011
0.883 ± 0.005
< 0.001
< 0.001
< 0.01
< 0.001
inhibition, there were significant differences in the
inhibition due to monoethanolamine depending on the
assay temperature (tab. 1). The inhibition at 25 °C is
greater than that observed at 37°C. In the case of a
recently recommended conversion of activities measured
at different assay temperatures (9), this could lead to a
considerable error, depending on the isoenzyme com-
position of serum.
Additions of triethanolamine up to a concentration of
40 mmol/l to the test solution, i. e. up to a content of
4% triethanolamine in 1 mol/1 diethanolamine, had no
influence on determined activities.
Gas Chromatographie analysis of diethanolamine samples
from three reputable chemical producers, showed
impurities of 1.5, 5.8 and 6,4% monoethanolamine.
This shows clearly that an undistilled and unchecked
commercial product should never be used for preparation
of the diethanolamirie buffer. As a gas Chromatographie
assay of purity seems to be unavoidable, the production
of the necessary buffer solutions by laboratories would
be inconvenient. For measuring alkaline phosphatase
and alkaline phosphatase isoenzymes by means of
diethanolamine buffer, only checked test combinations
should therefore be used.
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